Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
PAVmed Inc. reports that the Craig Kallman 2015 Living Trust beneficially owns 399,752 shares of common stock, or 4.9% of the class. Craig Kallman may also be deemed to beneficially own those same shares because he controls the Trust. Both are listed with sole voting and dispositive power over 399,752 shares, and zero shared voting and dispositive power. The reported ownership percentages are based on 7,995,918 shares outstanding as of August 13, 2026.
Key Figures
Shares beneficially owned by the Trust:399,752 sharesBeneficial ownership percentage:4.9%Common shares outstanding:7,995,918 shares
3 metrics
Shares beneficially owned by the Trust399,752 sharesThe shares are held by the Craig Kallman 2015 Living Trust; Craig Kallman may also be deemed to beneficially own them because he controls the Trust.
Beneficial ownership percentage4.9%Reported for each of the Trust and Craig Kallman.
Common shares outstanding7,995,918 sharesAs of August 13, 2026; used to calculate the reported beneficial ownership percentage.
Key Terms
beneficial ownership, Sole Voting Power, Sole Dispositive Power, Shared Voting Power
4 terms
beneficial ownershipregulatory
"The percentage of beneficial ownership is calculated based on"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Sole Voting Powerregulatory
"Sole Voting Power 399,752.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
Sole Dispositive Powerregulatory
"Sole Dispositive Power 399,752.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Shared Voting Powerregulatory
"Shared Voting Power 0.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many PAVM shares does the Craig Kallman 2015 Living Trust beneficially own?
The Craig Kallman 2015 Living Trust beneficially owns 399,752 shares of PAVmed common stock.
What percentage of PAVM does Craig Kallman report beneficially owning?
Craig Kallman is reported as beneficially owning 4.9% of PAVmed common stock, based on 7,995,918 shares outstanding as of August 13, 2026.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
PAVmed Inc.
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
70387R502
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
70387R502
1
Names of Reporting Persons
Kallman Craig
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
399,752.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
399,752.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
399,752.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.9 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP Number(s):
70387R502
1
Names of Reporting Persons
Craig Kallman 2015 Living Trust
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
NEW YORK
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
399,752.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
399,752.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
399,752.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.9 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
PAVmed Inc.
(b)
Address of issuer's principal executive offices:
360 MADISON AVENUE, 360 MADISON AVENUE, NEW YORK, NEW YORK, 10017.
Item 2.
(a)
Name of person filing:
This Amendment No. 1 to Schedule 13G is filed by the Craig Kallman 2015 Living Trust ("Trust") and Craig Kallman ("Mr. Kallman," and together with the Trust, the "Reporting Persons"). Mr. Kallman controls the Trust. The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 99.1 to the original Schedule 13G, pursuant to which such Reporting Persons have agreed to file the Schedule 13G and all amendments thereto jointly in accordance with the provisions of Rule 13d-1(k) of the Act. Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party. The filing of this Schedule 13G should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the shares of Common Stock reported herein.
(b)
Address or principal business office or, if none, residence:
The principal business address of each of the Reporting Persons is 200 East 62nd Street, New York, New York, 10065.
(c)
Citizenship:
The Trust is a trust governed by the laws of New York. Mr. Kallman is a citizen of the United States.
(d)
Title of class of securities:
Common Stock, par value $0.001 per share
(e)
CUSIP No.:
70387R502
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
The Trust beneficially owns 399,752 shares of Common Stock. Mr. Kallman may be deemed to beneficially own the shares of Common Stock held by the Trust, because Mr. Kallman controls the Trust.
(b)
Percent of class:
Each of the Trust and Mr. Kallman beneficially owns 4.9% of the outstanding shares of Common Stock. The percentage of beneficial ownership is calculated based on 7,995,918 shares of Common Stock outstanding as of August 13, 2026, as set forth in the Company's quarterly report on Form 10-Q filed on August 13, 2026.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Trust: 399,752 shares
Mr. Kallman: 399,752 shares
(ii) Shared power to vote or to direct the vote:
Trust: 0 shares
Mr. Kallman: 0 shares
(iii) Sole power to dispose or to direct the disposition of:
Trust: 399,752 shares
Mr. Kallman: 399,752 shares
(iv) Shared power to dispose or to direct the disposition of:
Trust: 0 shares
Mr. Kallman: 0 shares
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
